- Home
- OPP vs KOD Comparison
OPP vs KOD Comparison
Compare OPP & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPP
- KOD
- Stock Information
- Founded
- OPP 2010
- KOD 2009
- Country
- OPP United States
- KOD United States
- Employees
- OPP N/A
- KOD N/A
- Industry
- OPP Finance/Investors Services
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPP Finance
- KOD Health Care
- Exchange
- OPP Nasdaq
- KOD Nasdaq
- Market Cap
- OPP 208.6M
- KOD 198.4M
- IPO Year
- OPP N/A
- KOD 2018
- Fundamental
- Price
- OPP $8.65
- KOD $9.35
- Analyst Decision
- OPP
- KOD Hold
- Analyst Count
- OPP 0
- KOD 4
- Target Price
- OPP N/A
- KOD $11.75
- AVG Volume (30 Days)
- OPP 108.0K
- KOD 556.4K
- Earning Date
- OPP 01-01-0001
- KOD 11-13-2025
- Dividend Yield
- OPP 14.41%
- KOD N/A
- EPS Growth
- OPP N/A
- KOD N/A
- EPS
- OPP N/A
- KOD N/A
- Revenue
- OPP N/A
- KOD N/A
- Revenue This Year
- OPP N/A
- KOD N/A
- Revenue Next Year
- OPP N/A
- KOD N/A
- P/E Ratio
- OPP N/A
- KOD N/A
- Revenue Growth
- OPP N/A
- KOD N/A
- 52 Week Low
- OPP $7.26
- KOD $1.92
- 52 Week High
- OPP $8.83
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- OPP 46.78
- KOD 52.81
- Support Level
- OPP $8.70
- KOD $8.91
- Resistance Level
- OPP $8.78
- KOD $10.20
- Average True Range (ATR)
- OPP 0.07
- KOD 0.75
- MACD
- OPP -0.00
- KOD -0.12
- Stochastic Oscillator
- OPP 34.62
- KOD 45.49
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.